Biden: Monkeypox threat doesn't rise to level of COVID-19

President Joe Biden is seeking to calm concerns about recent cases of monkeypox that have been identified in Europe and the United States

Via AP news wire
Monday 23 May 2022 07:25
Biden Asia
Biden Asia

President Joe Biden sought Monday to calm concerns about recent cases of monkeypox that have been identified in Europe and the United States, saying he did not see the need to institute strict quarantine measures.

Speaking in Tokyo a day after he said the virus was something “to be concerned about," Biden said, ”I just don’t think it rises to the level of the kind of concern that existed with COVID-19."

Monkeypox is rarely identified outside of Africa. But as of Friday, there were 80 confirmed cases worldwide, including at least two in the United States, and another 50 suspected ones. On Sunday, one presumptive case of monkeypox also was being investigated in Broward County in South Florida, which state health officials said appeared to be related to international travel.

Although the disease belongs to the same virus family as smallpox, its symptoms are milder. People usually recover within two to four weeks without needing to be hospitalized, but the disease occasionally is deadly.

Biden said the smallpox vaccine works for monkeypox. Asked whether the U.S. has enough stockpile of that vaccine to handle the monkeypox spread, Biden said, “I think we do have enough to deal with the likelihood of a problem.”

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in